Keyphrases
Breast Cancer
100%
Breast Cancer Risk
100%
Classification Score
89%
Risk Classification
60%
High Risk
60%
Genetic Testing
40%
Specific Intent
40%
Cancer Risk
40%
Germline mutation
40%
Checkpoint Pathway
30%
Good Manufacturing Practice
30%
Entry Costs
30%
BRCA2 Protein
30%
Companion Diagnostics
30%
Analytical Validity
30%
Bioassay Test
30%
BRCA1-associated Protein 1 (BAP1)
30%
Laboratory-developed Test
30%
Automated Analysis
30%
Game Changer
30%
Analysis Protocol
30%
Understanding Risk
30%
Chemical Flow
30%
Human Blood Cells
20%
Hazard Ratio
20%
Family History
20%
Clinical Laboratory
20%
Genetic Predisposition
20%
FDA-approved Drugs
20%
Personalized Medicine
20%
Unsatisfactory Outcome
20%
Response to Treatment
20%
Clinical Test
20%
Targeted Chemotherapy
20%
Cancer Families
20%
Pancreatic Cancer
20%
Mutation Effect
20%
Family Registry
20%
Cost Performance
20%
PARP Inhibitor (PARPi)
20%
Disease Onset
20%
Ovarian Cancer
20%
Phenotypic Effects
20%
Prostate Cancer
20%
Score-based
20%
Cyclin
20%
Selling
20%
Phosphorylation
20%
Nuclear Localization
20%
High-risk Women
20%
Assay Kit
20%
Cancer Risk Assessment
20%
United States
20%
Radiomimetic
20%
Double-strand Break Repair
20%
Clinical Utility
20%
Commercial Kits
20%
Variants of Uncertain Significance
20%
Comparable Accuracy
20%
Whole Blood Sample
20%
Medicine and Dentistry
Breast Cancer
100%
Cancer Risk
100%
Genetic Screening
28%
Germline Mutation
28%
Disease
28%
BRCA1 Protein
21%
BRCA2 Protein
21%
Health Care Cost
14%
High Risk Population
14%
Genetic Predisposition
14%
Family History
14%
Hazard Ratio
14%
Pancreas Cancer
14%
Ovarian Cancer
14%
Personalized Medicine
14%
Proliferating Cell Nuclear Antigen
14%
PARP Inhibitor
14%
Protein P53
14%
Diagnosis
14%
Blood Cell
14%
Cancer Risk Assessment
14%
Prostate Cancer
14%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Disease
28%
BRCA2 Protein
21%
BRCA1 Protein
21%
Good Manufacturing Practice
21%
Protein P53
14%
Cycline
14%
Pancreas Cancer
14%
Ovary Cancer
14%
Genetic Predisposition
14%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
14%
Prostate Cancer
14%
Chemotherapy
14%